FFA
LGND icon

Farther Finance Advisors’s Ligand Pharmaceuticals LGND Stock Holding History

Farther Finance Advisors’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$69.1K Sell
219
-499
-69% -$118K ﹤0.01% 2989
2026
Q1 		$143K Buy
718
+73
+11% +$14.4K ﹤0.01% 2256
2025
Q4 		$122K Sell
645
-34
-5% -$6.53K ﹤0.01% 2218
2025
Q3 		$120K Buy
679
+41
+6% +$6.09K ﹤0.01% 1922
2025
Q2 		$72.5K Buy
638
+5
+0.8% +$534 ﹤0.01% 1933
2025
Q1 		$66.4K Sell
633
-133
-17% -$15K ﹤0.01% 1753
2024
Q4 		$82.1K Sell
766
-10
-1% -$1.13K ﹤0.01% 1401
2024
Q3 		$77.7K Buy
776
+74
+11% +$7.45K ﹤0.01% 1427
2024
Q2 		$59.6K Buy
702
+625
+812% +$49.7K ﹤0.01% 1348
2024
Q1 		$5.67K Sell
77
-5
-6% -$369 ﹤0.01% 2009
2023
Q4 		$5.86K Buy
+82
New +$4.84K ﹤0.01% 1885

Other funds holding LGND

CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
WC
Woodstock Corp Boston, Massachusetts $1.2B AUM 26.37% 1-Year Est. Return
MNBTD
Moody National Bank Trust Division Galveston, Texas $1.21B AUM 38.93% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LTAS
Linden Thomas Advisory Services Charlotte, North Carolina $1.24B AUM 47.37% 1-Year Est. Return
TAM
Tealwood Asset Management Minneapolis, Minnesota $261M AUM 52.68% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return
PWG
Portside Wealth Group Provo, Utah $858M AUM 26.82% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Farther Finance Advisors's LGND Position: Q2 2026 in Review

Farther Finance Advisors reduced its Ligand Pharmaceuticals (LGND) stake by 69% in Q2 2026, selling an estimated $118K and leaving 219 shares worth $69.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2989.

Farther Finance Advisors first reported a position in LGND in Q4 2023 and has held it in 11 quarters since. The position peaked at $143K in Q1 2026. 36 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • Farther Finance Advisors held 219 shares of Ligand Pharmaceuticals worth $69.1K as of Q2 2026.
  • Farther Finance Advisors sold 499 Ligand Pharmaceuticals shares in Q2 2026, an estimated $118K.
  • Ligand Pharmaceuticals made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #2989 holding.
  • Farther Finance Advisors first reported a position in Ligand Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
  • Farther Finance Advisors's Ligand Pharmaceuticals position peaked at $143K in Q1 2026.
  • 36 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.